AMYLOIDOSIS
Clinical trials for AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to control rare protein disease affecting the heart
Disease control OngoingThis study tests a drug combination (daratumumab plus chemotherapy) in people newly diagnosed with AL amyloidosis, a rare disease where abnormal proteins build up in organs. It focuses on heart safety and how the drug works in different racial groups. About 151 participants will …
Matched conditions: AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New chemo formula may reduce side effects in blood cancer transplant
Disease control OngoingThis study tests a new version of the chemotherapy drug melphalan, called Captisol Enabled Melphalan, in 46 adults with multiple myeloma or AL amyloidosis who are getting a stem cell transplant. The new formulation is designed to be more stable and possibly cause fewer side effec…
Matched conditions: AMYLOIDOSIS
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC